Cleared for sale in U.S., Defibtech Lifeline PRO and ECG AEDs feature revolutionary color LCD video display and 3-lead ECG monitoring capability
Entire family of Defibtech AEDs now available to U.S. customers, providing outstanding lifesaving technology for virtually any need, budget or environment
Featuring a revolutionary color LCD video display and 3-lead ECG monitoring capability, the DefibtechLifeline™ PRO and Lifeline ECG automated external defibrillators (AEDs) have been cleared for sale in the U.S. market by the Food and Drug Administration. AEDs are designed to revive victims of sudden cardiac arrest, which strikes about 380,000 Americans each year and is the leading cause of death in the U.S.
“With the addition of the Lifeline PRO and ECG AEDs, the entire family of Lifeline AEDs is now available in the U.S.,” said Defibtech CEO Dr. Glenn W. Laub. “There are excellent options for every customer, no matter the budget or the need. With sudden cardiac arrest such a common and foreseeable occurrence, all workplaces and public places should take the reasonable precaution of having at least one AED onsite.”